In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal.
|Number of pages||8|
|Journal||European urology oncology|
|Publication status||Published - 2018|
- Radiology Nuclear Medicine and imaging
- General Medicine